Literature DB >> 34071065

The Microbiome as a Therapy in Pouchitis and Ulcerative Colitis.

Jean-Frédéric LeBlanc1, Jonathan P Segal2, Lucia Maria de Campos Braz1,3, Ailsa L Hart1,3.   

Abstract

The gut microbiome has been implicated in a range of diseases and there is a rapidly growing understanding of this ecosystem's importance in inflammatory bowel disease. We are yet to identify a single microbe that causes either ulcerative colitis (UC) or pouchitis, however, reduced microbiome diversity is increasingly recognised in active UC. Manipulating the gut microbiome through dietary interventions, prebiotic and probiotic compounds and faecal microbiota transplantation may expand the therapeutic landscape in UC. Specific diets, such as the Mediterranean diet or diet rich in omega-3 fatty acids, may reduce intestinal inflammation or potentially reduce the risk of incident UC. This review summarises our knowledge of gut microbiome therapies in UC and pouchitis.

Entities:  

Keywords:  ileoanal pouch inflammatory bowel disease; microbiota; ulcerative colitis

Year:  2021        PMID: 34071065     DOI: 10.3390/nu13061780

Source DB:  PubMed          Journal:  Nutrients        ISSN: 2072-6643            Impact factor:   5.717


  86 in total

1.  Findings From a Randomized Controlled Trial of Fecal Transplantation for Patients With Ulcerative Colitis.

Authors:  Noortje G Rossen; Susana Fuentes; Mirjam J van der Spek; Jan G Tijssen; Jorn H A Hartman; Ann Duflou; Mark Löwenberg; Gijs R van den Brink; Elisabeth M H Mathus-Vliegen; Willem M de Vos; Erwin G Zoetendal; Geert R D'Haens; Cyriel Y Ponsioen
Journal:  Gastroenterology       Date:  2015-03-30       Impact factor: 22.682

2.  Species-function relationships shape ecological properties of the human gut microbiome.

Authors:  Sara Vieira-Silva; Gwen Falony; Youssef Darzi; Gipsi Lima-Mendez; Roberto Garcia Yunta; Shujiro Okuda; Doris Vandeputte; Mireia Valles-Colomer; Falk Hildebrand; Samuel Chaffron; Jeroen Raes
Journal:  Nat Microbiol       Date:  2016-06-13       Impact factor: 17.745

Review 3.  Systematic review with meta-analysis: the management of chronic refractory pouchitis with an evidence-based treatment algorithm.

Authors:  J P Segal; N S Ding; G Worley; S Mclaughlin; S Preston; O D Faiz; S K Clark; A L Hart
Journal:  Aliment Pharmacol Ther       Date:  2016-12-23       Impact factor: 8.171

Review 4.  Human lactoferrin: a novel therapeutic with broad spectrum potential.

Authors:  E D Weinberg
Journal:  J Pharm Pharmacol       Date:  2001-10       Impact factor: 3.765

5.  Effect of probiotics (Lactobacillus plantarum 299 plus Bifidobacterium Cure21) in patients with poor ileal pouch function: a randomised controlled trial.

Authors:  J Bengtsson; I Adlerberth; A Östblom; P Saksena; T Öresland; L Börjesson
Journal:  Scand J Gastroenterol       Date:  2016-05-06       Impact factor: 2.423

6.  Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial.

Authors:  Paolo Gionchetti; Fernando Rizzello; Ulf Helwig; Alessandro Venturi; Karen Manon Lammers; Patrizia Brigidi; Beatrice Vitali; Gilberto Poggioli; Mario Miglioli; Massimo Campieri
Journal:  Gastroenterology       Date:  2003-05       Impact factor: 22.682

7.  Long-term treatment of ulcerative colitis with ciprofloxacin: a prospective, double-blind, placebo-controlled study.

Authors:  U M Turunen; M A Färkkilä; K Hakala; K Seppälä; A Sivonen; M Ogren; M Vuoristo; V V Valtonen; T A Miettinen
Journal:  Gastroenterology       Date:  1998-11       Impact factor: 22.682

8.  Effects of Low FODMAP Diet on Symptoms, Fecal Microbiome, and Markers of Inflammation in Patients With Quiescent Inflammatory Bowel Disease in a Randomized Trial.

Authors:  Selina R Cox; James O Lindsay; Sébastien Fromentin; Andrew J Stagg; Neil E McCarthy; Nathalie Galleron; Samar B Ibraim; Hugo Roume; Florence Levenez; Nicolas Pons; Nicolas Maziers; Miranda C Lomer; S Dusko Ehrlich; Peter M Irving; Kevin Whelan
Journal:  Gastroenterology       Date:  2019-10-02       Impact factor: 22.682

9.  Structure, function and diversity of the healthy human microbiome.

Authors: 
Journal:  Nature       Date:  2012-06-13       Impact factor: 49.962

10.  Effect of oral lactulose on clinical and immunohistochemical parameters in patients with inflammatory bowel disease: a pilot study.

Authors:  Anne Hafer; Sigrid Krämer; Swantje Duncker; Martin Krüger; Michael P Manns; Stephan C Bischoff
Journal:  BMC Gastroenterol       Date:  2007-09-04       Impact factor: 3.067

View more
  1 in total

Review 1.  Ileal Pouch-Anal Anastomosis and Pouchitis: The Role of the Microbiota in the Pathogenesis and Therapy.

Authors:  Roberto Gabbiadini; Arianna Dal Buono; Carmen Correale; Antonino Spinelli; Alessandro Repici; Alessandro Armuzzi; Giulia Roda
Journal:  Nutrients       Date:  2022-06-24       Impact factor: 6.706

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.